Non-diabetic hypoglycemia is a drop in blood sugar low enough to cause symptoms in someone who does not have diabetes. It is far less common than hypoglycemia in people taking insulin or other diabetes drugs, and confirming it requires what clinicians call Whipple’s triad: a documented low blood glucose reading, symptoms consistent with low blood sugar, and resolution of those symptoms once glucose returns to normal.1PubMed Central. Non-Diabetic Hypoglycemia: Evaluation and Management in Adults The causes range from rare pancreatic tumors to medication side effects to the aftermath of weight-loss surgery, and sorting out which one is responsible can be genuinely difficult.
What the Symptoms Feel Like
Hypoglycemia produces two distinct categories of symptoms, and recognizing the difference matters because they kick in at different blood sugar thresholds and carry different levels of urgency. The first wave is driven by the autonomic nervous system reacting to falling glucose: trembling, a pounding heart, sweating, anxiety, hunger, and tingling sensations around the mouth or fingers. These are your body’s alarm signals, and they tend to appear first.2PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness
If blood sugar keeps dropping, the brain itself starts running short on fuel. That produces a second, more dangerous set of symptoms: confusion, difficulty concentrating, a sensation of warmth, weakness, visual disturbances, personality or behavioral changes, and in severe cases seizures or loss of consciousness.3PubMed Central. Diagnosis and management of insulinoma People experiencing these brain-level symptoms often cannot help themselves and need someone else to intervene.
A tricky wrinkle is that repeated episodes can shift the glucose threshold at which warning symptoms appear, pushing it lower. Over time, a person can lose those early alarm signals entirely, a phenomenon called hypoglycemia unawareness. Without the trembling and sweating as an early heads-up, the first sign of trouble may be confusion or even a seizure.4PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness
When the Pancreas Makes Too Much Insulin
The most talked-about cause of non-diabetic hypoglycemia is an insulinoma, a small tumor of the insulin-producing cells in the pancreas. Insulinomas occur in roughly one to four people per million, making them rare but not vanishingly so among the conditions that endocrinologists evaluate.5PubMed Central. Diagnosis and management of insulinoma About 90% of insulinomas are benign and solitary, and surgical removal is usually curative.6PubMed Central. Insulinoma: Presenting as hypoglycemia in a non-diabetic patient: A rare case report The classic pattern is fasting hypoglycemia: blood sugar drops after not eating for several hours, often overnight or in the early morning, rather than after meals.
A related but even rarer condition is non-insulinoma pancreatogenous hypoglycemia syndrome, sometimes called nesidioblastosis in adults. Here, there is no discrete tumor. Instead, the insulin-producing tissue throughout the pancreas is overactive or structurally abnormal. Because there is no single mass to find on a scan, it tends to be diagnosed late and is often initially mistaken for an insulinoma.7PubMed Central. Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS)/Nesidioblastosis as the underlying cause of recurrent hypoglycemia in a diabetic adult The symptoms are nonspecific, overlapping heavily with the general symptom picture described above, which is part of the reason it is frequently overlooked.8PubMed Central. Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia The definitive diagnosis requires examining pancreatic tissue under a microscope, and treatment typically involves surgical removal of part of the pancreas.9PubMed Central. Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS)/Nesidioblastosis as the underlying cause of recurrent hypoglycemia in a diabetic adult
Hypoglycemia After Weight-Loss Surgery
Post-bariatric hypoglycemia has become the most commonly encountered form of non-diabetic hypoglycemia in clinical practice, simply because gastric bypass procedures are so much more common than insulinomas. The pattern is different from an insulinoma: blood sugar crashes occur after eating rather than during fasting, usually one to three hours after a meal.
The mechanism is multifactorial but centers on how drastically gastric bypass rearranges the digestive tract. Food bypasses the stomach’s natural holding area and hits the small intestine quickly, causing a rapid spike in blood sugar. That spike triggers an outsized insulin response, partly because of a gut hormone called GLP-1, whose post-meal secretion increases roughly tenfold after bypass surgery.10The Journal of Clinical Endocrinology & Metabolism. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies The combination of faster nutrient delivery and a supercharged incretin effect drives insulin far higher than the glucose load warrants, and blood sugar plummets.11PubMed. Hypoglycaemia after gastric bypass: mechanisms and treatment
Management usually starts with dietary changes: smaller, more frequent meals that are low in simple sugars and higher in protein and fiber, which slow the glucose spike. Medications that blunt insulin secretion or slow gastric emptying are sometimes used when diet alone is not enough. In rare, severe cases, surgical revision or partial pancreatectomy has been considered, but the evidence for these approaches is still evolving.
Tumors That Are Not on the Pancreas
Some large, slow-growing tumors located far from the pancreas can cause severe hypoglycemia through an entirely different pathway. These produce an abnormal, oversized form of a hormone called IGF-II (insulin-like growth factor II), which can mimic insulin’s effects on blood sugar.12PubMed Central. Management of non-islet-cell tumor hypoglycemia: a clinical review The condition is called non-islet cell tumor hypoglycemia, and it has been reported with fibrosarcomas, mesotheliomas, and other large mesenchymal or epithelial tumors.13PubMed. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia
Under normal circumstances, IGF-II circulates bound to large protein complexes that are too bulky to cross from blood vessels into tissues easily. The oversized “big IGF-II” produced by these tumors forms smaller complexes that slip into tissue fluid much more readily, increasing the amount of IGF reaching cells by roughly four to five times. That flood of IGF activity drives glucose into cells the same way insulin would, pulling blood sugar dangerously low.14PubMed Central. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors Tumor removal eliminates most of the big IGF-II from the bloodstream, and hypoglycemia resolves.15PubMed Central. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors
Medications and Alcohol
You do not have to be taking diabetes drugs to experience drug-induced hypoglycemia. A wide range of medications used in everyday practice can lower blood sugar, including certain antibiotics, antimalarials, heart rhythm drugs, anti-inflammatory painkillers, and antidepressants.16PubMed. Drug-induced hypoglycaemia: an update The mechanisms vary: some stimulate insulin release, some reduce the body’s clearance of circulating insulin, and others interfere with the liver’s ability to produce glucose.
In a large review of over 1,400 cases of drug-induced hypoglycemia, diabetes drugs still accounted for the majority of episodes, but alcohol, beta-blockers, and salicylates (the aspirin family) together were responsible for about a fifth of all cases. Quinine, pentamidine, and disopyramide (a heart rhythm drug) caused an additional fraction.17PubMed. Drug-induced hypoglycemia. A review of 1418 cases Alcohol deserves special mention because it blocks the liver’s ability to release stored glucose, and the risk increases substantially if someone drinks on an empty stomach or after prolonged fasting. The combination of alcohol with any other drug that lowers blood sugar makes the risk considerably worse.
Organ Failure, Critical Illness, and Hormonal Gaps
The liver is responsible for producing glucose between meals, so advanced liver disease can directly cause hypoglycemia when the organ can no longer keep up. Similarly, the kidneys play a role in glucose regulation and in clearing insulin from the bloodstream; severe kidney dysfunction can tip the balance toward low blood sugar. Sepsis, the body’s overwhelming response to infection, can burn through glucose stores and simultaneously impair the liver’s output, making hypoglycemia a recognized complication of critical illness.18South Asian Research Journal of Medical Sciences. Refractory Hypoglycemia in Non-Diabetic Patient: A Case Report
Hormonal deficiencies round out this category. Cortisol, produced by the adrenal glands, is one of the body’s main counter-regulatory hormones: it pushes blood sugar up when it falls too low. Adrenal insufficiency, whether from autoimmune destruction, pituitary disease, or abrupt withdrawal of steroid medications, removes that safety net. Growth hormone deficiency can have a similar, though usually milder, effect. In adults, isolated hormonal deficiency as a sole cause of hypoglycemia is uncommon, but when it occurs alongside fasting or illness it can tip the balance.
Autoimmune Insulin Syndrome
Insulin autoimmune syndrome, also known as Hirata disease, is a peculiar condition in which the body’s own immune system produces antibodies that bind to insulin. The mechanism creates a two-phase problem. After eating, the antibodies grab insulin before it can act, sometimes leading to mild high blood sugar. Later, insulin detaches from the antibodies unpredictably and floods the bloodstream regardless of what blood sugar is doing at the time, causing hypoglycemia.19PubMed Central. Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description
Hirata disease is rare globally, with roughly 380 cases reported worldwide between 1970 and 2009, but it is more common in Japan and other East Asian populations. Certain medications can trigger it: in a Japanese series, drug-induced forms accounted for about 43% of cases.20PubMed Central. Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description In many patients the condition resolves on its own once the triggering drug is stopped, though some require immunosuppressive treatment.
How Doctors Figure Out the Cause
Because the list of possible causes is long and several of them look alike on the surface, the diagnostic workup for non-diabetic hypoglycemia follows a structured approach. The centerpiece for suspected fasting hypoglycemia is the supervised 72-hour fast, performed in a hospital. Blood sugar is monitored at regular intervals, switching to hourly checks once it drops below 60 mg/dL. The fast continues until the patient becomes hypoglycemic (blood sugar below 45 mg/dL with symptoms) or until 72 hours pass without an episode. At the end, blood is drawn for insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and a screen for diabetes drugs, and then the patient receives an injection of glucagon to see how the body responds.21Endocrine Practice. Impact of the Addition of Beta-Hydroxybutyrate in the 72-Hour Fast Protocol on Hospitalization Duration: A Quality Improvement Report
The pattern of results from that blood draw tells clinicians a lot. An insulinoma shows up as elevated insulin, C-peptide, and proinsulin together with low blood sugar, because the tumor is producing all the components of insulin in the normal ratio. By contrast, if someone has been injecting insulin from an outside source, the insulin level will be high but C-peptide will be suppressed, because the body’s own insulin production shuts down when blood sugar drops. The ratio of insulin to C-peptide becomes a powerful diagnostic clue: if it exceeds 1.0, exogenous insulin is almost certainly the explanation.22JAMA Internal Medicine. The Molar Ratio of Insulin to C-Peptide: An Aid to the Diagnosis of Hypoglycemia due to Surreptitious (or Inadvertent) Insulin Administration
Localization testing follows once the biochemistry points to a specific cause. For suspected insulinomas, imaging with CT or endoscopic ultrasound is the first step. When those are inconclusive, selective arterial calcium stimulation can help pinpoint the area of the pancreas responsible for excess insulin secretion. In a Spanish multicenter study of post-bariatric hypoglycemia, standard imaging was unremarkable in several patients, but calcium stimulation testing was positive in some of them, guiding further management.23Obesity Facts. Hyperinsulinemic Hypoglycemia after Bariatric Surgery: Diagnosis and Management Experience from a Spanish Multicenter Registry
Factitious Hypoglycemia and Why It Gets Missed
Factitious hypoglycemia, where someone deliberately or accidentally takes insulin or an insulin-stimulating drug, is an uncomfortable diagnosis to consider but an important one. Healthcare workers with access to insulin, family members of people with diabetes, and individuals with certain psychiatric conditions are at higher risk. It can also happen accidentally when a non-diabetic person takes someone else’s medication by mistake.
The insulin-to-C-peptide ratio described above is the key to catching it. Under normal conditions, the pancreas releases insulin and C-peptide in equal amounts, but the liver clears much of the insulin before it reaches the rest of the body while letting C-peptide pass through freely. Injected insulin skips the liver entirely, so peripheral blood shows disproportionately high insulin relative to C-peptide.24JAMA Internal Medicine. The Molar Ratio of Insulin to C-Peptide: An Aid to the Diagnosis of Hypoglycemia due to Surreptitious (or Inadvertent) Insulin Administration A sulfonylurea screen catches cases where the offending agent is a pill rather than an injection. Without these specific tests, factitious hypoglycemia can masquerade as an insulinoma for months or years.
Inherited Conditions That Show Up Late
Some genetic metabolic disorders, traditionally thought of as childhood diseases, occasionally surface for the first time in adulthood. Glycogen storage diseases, for example, impair the body’s ability to break down stored glycogen into glucose during fasting. One case report describes a 48-year-old woman with recurrent non-diabetic hypoglycemia, mostly occurring overnight and while fasting, who was eventually diagnosed with glycogen storage disease type VI after the workup excluded insulin-driven causes.25Endocrine Abstracts. A challenging case of adult-onset non-diabetic hypoglycemia: unveiling glycogen storage disease type vi (hers disease) These cases are unusual, but they highlight that when the standard endocrine workup comes back clean, metabolic causes related to how the body stores and mobilizes fuel deserve a look.
Congenital hyperinsulinism from inherited mutations in the potassium channels that regulate insulin release is another condition that can persist unrecognized well into adulthood. In a study of 16 families with dominant mutations affecting these channels, roughly half of the adult mutation carriers (15 out of 29 people older than 18) still had persistent symptoms of hypoglycemia, some into their late sixties. Others in the same families carried the same mutation but never complained of symptoms at all.26JCI Insight. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations The variation even within a single family is striking: diagnosis was often delayed for years because the symptoms were nonspecific and the condition was not on anyone’s radar.
The Limits of Continuous Glucose Monitors
With the growing availability of consumer continuous glucose monitors, more people without diabetes are tracking their blood sugar in real time. Some discover apparent dips into the low range and worry about hypoglycemia. Context matters here. CGMs measure glucose in the fluid between cells, not directly in the blood, and there is a time lag. Studies in people with normal blood sugar have shown that CGM readings tend to run higher than simultaneous venous blood glucose during the daytime, which can produce misleading readings around any cutoff you set.27PLoS ONE. Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals
A CGM showing a glucose value in the 60s does not, on its own, confirm clinically meaningful hypoglycemia. The standard remains Whipple’s triad: a low glucose reading, the presence of characteristic symptoms, and relief when glucose comes back up. If a CGM trace suggests frequent lows but you feel perfectly fine during those readings, the episodes may be sensor artifacts rather than true hypoglycemia. Conversely, if the readings align with symptoms you can feel, the data becomes a useful tool for showing your doctor the timing and pattern of your episodes, which can guide the diagnostic workup toward meal-related versus fasting causes.
Reactive Hypoglycemia and the Grey Zone
The term “reactive hypoglycemia” describes low blood sugar that occurs within a few hours after eating, usually after a carbohydrate-heavy meal, in people who have not had bariatric surgery and have no identifiable tumor or hormonal deficiency. It is the most commonly self-diagnosed form of hypoglycemia, and also one of the most debated in endocrinology. Many people experience post-meal symptoms that feel like low blood sugar, including shakiness, brain fog, and irritability, but when their glucose is actually measured during those symptoms it is often in the normal range.
True reactive hypoglycemia, confirmed with Whipple’s triad, does occur but is less common than the symptom pattern alone would suggest. When it is real, the usual management is dietary: spreading meals out, pairing carbohydrates with protein and fat, and avoiding large loads of refined sugar. No medication has strong evidence for routine use in this setting. If the episodes are severe, recurrent, and confirmed with documented low glucose, the workup should proceed as for any other case of non-diabetic hypoglycemia, because conditions like early post-bariatric physiology changes or even mild nesidioblastosis can present in a postprandial pattern.28PubMed Central. Non-Diabetic Hypoglycemia: Evaluation and Management in Adults
The grey zone between “real reactive hypoglycemia” and “post-meal symptoms without measurably low glucose” is where a lot of frustration lives, both for patients and for their doctors. If your blood sugar genuinely drops below the threshold during symptoms, the workup is warranted. If it does not, the symptoms may have a different explanation entirely, such as postprandial changes in blood pressure or gut hormones that mimic the feeling of a low without the glucose actually being low.